UPDATE: H.C. Wainwright Initiates Coverage on PharmAthene
March 10, 2014 at 16:12 PM EDT
In a report published Monday, H.C. Wainwright & Co. analyst Andrew Fein initiated coverage on PharmAthene (NYSE: PIP) with a Buy rating ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.